FORGOTTEN HISTORY: Horizon rapeutics - Caught on Camera

Amgen to buy Horizon Therapeutics in $26.4B deal

Horizon Therapeutics, whose U.S. headquarters is in Deerfield, is a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases.

Chicago Sun-Times · Dec 12, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022

Upgrades

Benzinga · Aug 4, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

 

Benzinga · Aug 3, 2022

Horizon Therapeutics: Q1 Earnings Insights

  Horizon Therapeutics (NASDAQ:HZNP) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 4, 2022

Will Investors Notice Exciting Sign On Horizon Therapeutics's Chart?

If history is any guide, there may be good fortune ahead for shares of Horizon Therapeutics (NASDAQ:HZNP). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga · Apr 28, 2022

Horizon Therapeutics Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, Horizon Therapeutics (NASDAQ:HZNP) posted Q4 earnings of $173.18 million, an increase from Q3 of 46.97%. Sales dropped to $1.01 billion, a 2.22% decrease between quarters.

Benzinga · Mar 4, 2022